The UK life sciences sector is undergoing a transformation driven by multi-omics and AI-integrated drug discovery. Effective pharmaceutical market research UK is essential for navigating the evolving IP landscape and GLP-1 therapy competition.
UK Pharmaceutical Market Research Update
By Laura McConaughey
Category: Healthcare Research
Executive Summary
• UK pharma is dominated by GLP-1 competition and AI integration. • Navigating the new IP hurdles for AI-assisted discoveries is critical for 2026.
Frequently Asked Questions
What are the top therapeutic areas in the UK for 2026?
Metabolic diseases (GLP-1s), oncology, and advanced cell therapies.